Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nanotechnology: a focus on nanoparticles as a drug delivery system.

Literature DB >> 18040810

Nanotechnology: a focus on nanoparticles as a drug delivery system.

Jeffrey D Kingsley¹, Huanyu Dou, Justin Morehead, Barrett Rabinow, Howard E Gendelman, Christopher J Destache.

Abstract

This review will provide an in-depth discussion on the previous development of nanoparticle-based drug delivery systems (DDS) and discuss original research data that includes the therapeutic enhancement of antiretroviral therapy. The use of nanoparticle DDS will allow practitioners to use drugs to target specific areas of the body. In the treatment of malignancies, the use of nanoparticles as a DDS is making measurable treatment impact. Medical imaging will also utilize DDS to illuminate tumors, the brain, or other cellular functions in the body. The utility of nanoparticle DDS to improve human health is potentially enormous.

Entities: Disease Species

Mesh：

Substances：

Year: 2006 PMID： 18040810 DOI： 10.1007/s11481-006-9032-4

Source DB: PubMed Journal: J Neuroimmune Pharmacol ISSN： 1557-1890 Impact factor: 4.147

117 in total

1. Ultrahigh-resolution multicolor colocalization of single fluorescent probes.

Authors: T D Lacoste; X Michalet; F Pinaud; D S Chemla; A P Alivisatos; S Weiss
Journal: Proc Natl Acad Sci U S A Date: 2000-08-15 Impact factor: 11.205

Review 2. Nano and microparticles as controlled drug delivery devices.

Authors: M N Ravi Kumar
Journal: J Pharm Pharm Sci Date: 2000 May-Aug Impact factor: 2.327

3. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking.

Authors: Maxime Dahan; Sabine Lévi; Camilla Luccardini; Philippe Rostaing; Béatrice Riveau; Antoine Triller
Journal: Science Date: 2003-10-17 Impact factor: 47.728

Review 4. Small-scale systems for in vivo drug delivery.

Authors: David A LaVan; Terry McGuire; Robert Langer
Journal: Nat Biotechnol Date: 2003-10 Impact factor: 54.908

5. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Authors: E Olsen; M Duvic; A Frankel; Y Kim; A Martin; E Vonderheid; B Jegasothy; G Wood; M Gordon; P Heald; A Oseroff; L Pinter-Brown; G Bowen; T Kuzel; D Fivenson; F Foss; M Glode; A Molina; E Knobler; S Stewart; K Cooper; S Stevens; F Craig; J Reuben; P Bacha; J Nichols
Journal: J Clin Oncol Date: 2001-01-15 Impact factor: 44.544

6. Microscopic localization of PEG-liposomes in a rat model of focal infection.

Authors: P Laverman; E T Dams; G Storm; T G Hafmans; H J Croes; W J Oyen; F H Corstens; O C Boerman
Journal: J Control Release Date: 2001-08-10 Impact factor: 9.776

7. Extended CSF cytarabine exposure following intrathecal administration of DTC 101.

Authors: S Kim; E Chatelut; J C Kim; S B Howell; C Cates; P A Kormanik; M C Chamberlain
Journal: J Clin Oncol Date: 1993-11 Impact factor: 44.544

8. Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats.

Authors: R Löbenberg; L Araujo; H von Briesen; E Rodgers; J Kreuter
Journal: J Control Release Date: 1998-01-02 Impact factor: 9.776

Review 9. Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experience.

Authors: Alejandra T Perez; Gabriel H Domenech; Cynthia Frankel; Charles L Vogel
Journal: Cancer Invest Date: 2002 Impact factor: 2.176

Review 10. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Authors: Sonu Sundd Singh
Journal: Curr Drug Metab Date: 2006-02 Impact factor: 3.731

48 in total

1. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors: A V Kabanov; H E Gendelman
Journal: Prog Polym Sci Date: 2007 Impact factor: 29.190

Review 2. Translational research models and novel adjunctive therapies for neuroAIDS.

Authors: M Christine Zink
Journal: J Neuroimmune Pharmacol Date: 2007-01-09 Impact factor: 4.147

3. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.

Authors: Kai Xiao; Juntao Luo; Wiley L Fowler; Yuanpei Li; Joyce S Lee; Li Xing; R Holland Cheng; Li Wang; Kit S Lam
Journal: Biomaterials Date: 2009-08-05 Impact factor: 12.479

Review 4. The role of nanotechnology in the treatment of viral infections.

Authors: Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal: Ther Adv Infect Dis Date: 2017-07-05

5. Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.

Authors: Jorge F Coelho; Paula C Ferreira; Patricia Alves; Rosemeyre Cordeiro; Ana C Fonseca; Joana R Góis; Maria H Gil
Journal: EPMA J Date: 2010-04-10 Impact factor: 6.543

6. Antiproliferative effects of ZnO, ZnO-MTCP, and ZnO-CuMTCP nanoparticles with safe intensity UV and X-ray irradiation.

Authors: Susan Sadjadpour; Shahrokh Safarian; Seyed Jalal Zargar; Nader Sheibani
Journal: Biotechnol Appl Biochem Date: 2015-04-15 Impact factor: 2.431

7. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Authors: Ari S Nowacek; Reagan L Miller; Joellyn McMillan; Georgette Kanmogne; Michel Kanmogne; R Lee Mosley; Zhiya Ma; Sabine Graham; Mahesh Chaubal; Jane Werling; Barrett Rabinow; Huanyu Dou; Howard E Gendelman
Journal: Nanomedicine (Lond) Date: 2009-12 Impact factor: 5.307